Despite decades of progress in oncology, ranging from molecular diagnostics to targeted therapies, cancer remains one of medicine’s most complex and costly challenges. While genomic sequencing and AI-assisted analytics have improved disease classification, biomarker identification, and the discovery of drugs that may help, most patients are still treated using standardized protocols driven by population-level data […]
